Flunked out of the clinical trial! I begged to stay on, but the protocol is that with a 1.4 x 1.0 cm lymph node on my paratracheal, SUV 7.5, I have progression and have to try something else. Oncologist dismissed going back on Ibrance after holiday, says that works for few people. (She also said I went off Ibrance because of a rash! That is false. How do I get her to change it?( Reports also say I had a physical exam, listening to heart and lung, and she has never done that.) I had Ibrance and Fulvestrant at first, worked well for 2 years, then she concluded that Fulvestrant failed. I wondered why she didn't say they both failed. I stopped both at the same time. I had a rash from Xgeva.
I was on the oral SERD for one year. She presented the options as letrozole oe exemestane as hormonal, plus abemaciclib (verzenio) or ribociclib as CDK4/6 inhibitor, or Xeloda as chemo. She chose letrozole or verzenio, and gave me no choice and little explanation. I kept interrupting her as she explained very slowly an simply as though I were two and had not learned anything here. I wanted more info, not what I already knew. Didn't work.
Starting at 150. She said diarrhea kicks in about 3 weeks in -- when I will be away. I can start Letrozole today, and Verzenio next week, when I have an appointment for "education." I am looking back at posts on people's experiences with those two. Ach, hair loss again. In the summer. My hair thinned badly on Ibrance, so I assume it will be the same.I pointed out to her that this tumor, on r. paratracheal, has not responded as the others to estrogen blockers. She said that doesn't mean this on won't work. I had zero estrogen on the oral SERD, yet this one grew, so I don't understand how another one can work better.